SYM

Symbotic is executing a genuine growth story: revenue compounded from $252M (FY2021) to $2.25B (FY2025), up 25.7% YoY, while gross profit jumped 72% to $423M and gross margin expanded to 18.8% — evidence the systems business is scaling toward operating leverage rather than buying revenue at flat margins. The MD&A frames a real demand inflection in AI-powered supply-chain automation, anchored by an approximately $22.5B backlog dominated by Walmart and the GreenBox JV, ~1,100 patents, and the January 2025 ASR acquisition plus 2025 Walmart Master Automation Agreement that open a new micro-fulfillment category. Operating cash flow of $867M and $1.24B of cash (up 71.2%) give it the runway to fund $216M of R&D and keep deploying.

The other side is just as concrete. The company remains GAAP-unprofitable — net loss of -$16.9M, operating loss of -$115M (operating margin -5.1%), diluted EPS -$0.16 and a negative P/E of -260.5 — and management itself flags a 'limited operating history and a history of losses' with no assurance of near-term profitability. Accumulated deficit is -$1.34B. The headline liabilities/equity of 8.67x looks like balance-sheet stress, but it is driven by current liabilities ($1.73B, +70%) tied to milestone/contract billings rather than disclosed financial debt; with $1.89B current assets and $1.24B cash, liquidity is adequate. More worrying is the disclosed material weakness in internal control over financial reporting, plus heavy customer concentration (Walmart, GreenBox, and affiliate C&S Wholesale Grocers) and execution risk on the GreenBox warehouse-as-a-service JV.